Today’s cyclodextrin research highlights a promising new therapy for inflammation-related diseases and oxidative damage. Researchers have presented a new anti-inflammatory and antioxidant nanoparticle, LCD, which aims to protect against severe burn-induced intestinal injury. With traditional methods showing limitations, the application of nanoparticles like LCD could offer a much-needed protective strategy for the intestinal barrier.
